As of April 16, 2025, Xeris Pharmaceuticals (XERS) has a market cap of $0.67 billion USD. According to our data, Xeris Pharmaceuticals is ranked No.5580 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.67 B |
33.41%
|
Dec 31, 2024 | $0.51 B |
44.26%
|
Dec 29, 2023 | $0.35 B |
76.69%
|
Dec 30, 2022 | $0.20 B |
-54.61%
|
Dec 31, 2021 | $0.44 B |
-40.45%
|
Dec 31, 2020 | $0.73 B |
-30.21%
|
Dec 31, 2019 | $1.05 B |
-58.53%
|
Dec 31, 2018 | $2.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
Market Cap | = | XERS Stock Price | * | XERS Shares Outstanding |
= | $4.38 | * | 0.15 B | |
= | $0.67 B |